U.S. Physical Therapy, Inc.
USPH
$77.33
-$0.02-0.03%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 1.68% | 7.85% | |||
| Total Other Revenue | 2.81% | 5.19% | |||
| Total Revenue | 1.87% | 7.39% | |||
| Cost of Revenue | 13.38% | -4.32% | |||
| Gross Profit | -27.22% | 55.47% | |||
| SG&A Expenses | 4.33% | 8.24% | |||
| Depreciation & Amortization | -68.97% | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.40% | 8.95% | |||
| Operating Income | -12.44% | -5.37% | |||
| Income Before Tax | -5.43% | 48.52% | |||
| Income Tax Expenses | -33.77% | 127.75% | |||
| Earnings from Continuing Operations | 7.80% | 27.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -9.82% | -3.21% | |||
| Net Income | 7.09% | 39.47% | |||
| EBIT | -12.44% | -5.37% | |||
| EBITDA | -8.56% | 1.43% | |||
| EPS Basic | 52.24% | 35.83% | |||
| Normalized Basic EPS | -33.09% | -15.55% | |||
| EPS Diluted | 52.24% | 35.83% | |||
| Normalized Diluted EPS | -33.09% | -15.55% | |||
| Average Basic Shares Outstanding | 0.28% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.28% | 0.08% | |||
| Dividend Per Share | 2.27% | 0.00% | |||
| Payout Ratio | -- | -0.28% | |||